Why is Broad Injectables the biggest and best third party injection manufacturers in India?
Broad Injectables is the biggest company among third party injection manufacturers in India and has provided its services for several years. All over the country, we are known for our high-quality injectables that are fully certified by the GMP, iso, and WHO. In our large, state-of-the-art manufacturing facilities, we produce a huge collection of various types of injections. In our product list, we have added artesunate, cefoperazone and sulbactam, ceftriaxone and sulbactam, doxycycline for injections, and many other ranges as well. Moreover, because of our special team in R&D, we constantly develop a new range of healthcare products, allow our customers to always deal in the injection range, and lead their marketplaces.
Define the genuine quality products offered by leading third party injection manufacturers in India, Broad Injectables.
When creating high-quality injectables, our company uses precise measures to assure their safety, effectiveness, and regulatory compliance. Here’s a thorough summary of the procedure:
1. Formulation development: We first determine active pharmaceutical ingredients (API) because excipients are most suitable for the planned injectable product. Also, we do substantial studies and analyses to assure stability, bioavailability, and compatibility.
2. Optimization: In this segment, we develop a robust manufacturing process that ensures consistency and quality in our injunctions. This includes optimizing parameters such as temperature, pH, mixing speeds, and sterilization methods. Moreover, we involve pilot-scale production to identify and mitigate any issues that may arise during full-scale production.
3. Sterile manufacturing: We always ensure that all manufacturing processes are carried out in a sterile environment to prevent contamination.This includes the use of cleanrooms, laminar flow hoods, and sterilized equipment. In addition, we use appropriate sterilization methods such as autoclaving, dry heat sterilization, filtration, and radiation. However, the choice of method depends on the nature of the product and its components.
4. Process development: Our special team in production optimizes manufacturing processes for consistency and the quality of our connections. Adjusting factors, including temperature, pH, mixing rates, and sterilization procedures, are part of this.
5. Filling and sealing: The use of aseptic filling involves transferring the sterile product into pre-sterilized containers (vials, ampoules, and syringes) using aseptic procedures. In this process, we carried out rigorous aseptic conditions to avoid contamination. Moreover, we ensure sterility and immediately seal the containers.
6. Quality control and testing: Lastly, we monitor important parameters to verify that the process adheres to set criteria. This involves measuring pH, osmolarity, and particulate matter. Also, we conduct comprehensive testing on the finished product to verify that it fulfills quality requirements.
As a result, we can produce the only genuine range of injections and other healthcare products as well, which allows us to be the most trusted injection manufacturer in India.
S.No. | Generic Name & Dosage Form | Composition | Spc. | Qty. | Unit |
---|---|---|---|---|---|
1 | Artesunate | Each vial contains: | |||
Injection | Artesunate (Sterile) | IP | 60 | mg | |
2 | Cefoperazone and | Each vial contains: | |||
Sulbactam For Injection | Cefoperazone Sodium (Sterile) | IP | |||
Eq. to Cefoperazone | 1000 | mg | |||
Sulbactam Sodium (Sterile) | IP | ||||
Eq. to Sulbactam | 500 | mg | |||
3 | Cefoperazone and | Each vial contains: | |||
Sulbactam For Injection | Cefoperazone Sodium (Sterile) | IP | |||
Eq. to Cefoperazone | 500 | mg | |||
Sulbactam Sodium (Sterile) | IP | ||||
Eq. to Sulbactam | 500 | mg | |||
4 | Ceftriaxone and Sulbactam | Each vial contains: | |||
For Injection IP | Ceftriaxone Sodium (Sterile) | IP | |||
Eq. to Ceftriaxone | 1000 | mg | |||
Sulbactam Sodium (Sterile) | IP | ||||
Eq. to Sulbactam | 500 | mg | |||
5 | Ceftriaxone and Sulbactam | Each vial contains: | |||
For Injection IP | Ceftriaxone Sodium (Sterile) | IP | |||
Eq. to Ceftriaxone | 500 | mg | |||
Sulbactam Sodium (Sterile) | IP | ||||
Eq. to Sulbactam | 250 | mg | |||
6 | Ceftriaxone and Sulbactam | Each vial contains: | |||
For Injection IP | Ceftriaxone Sodium (Sterile) | IP | |||
Eq. to Ceftriaxone | 250 | mg | |||
Sulbactam Sodium (Sterile) | IP | ||||
Eq. to Sulbactam | 125 | mg | |||
7 | Ceftriaxone and Tazobactam | Each vial contains: | |||
For Injection | Ceftriaxone Sodium (Sterile) | IP | |||
Eq. to Ceftriaxone | 1000 | mg | |||
Tazobactam Sodium (Sterile) | IP | ||||
Eq. to Tazobactam | 125 | mg | |||
8 | Ceftriaxone | Each vial contains: | |||
Injection IP | Ceftriaxone Sodium (Sterile) | IP | |||
Eq. to Ceftriaxone | 250 | mg | |||
9 | Ceftriaxone | Each vial contains: | |||
Injection IP | Ceftriaxone Sodium (Sterile) | IP | |||
Eq. to Ceftriaxone | 500 | mg | |||
10 | Ceftriaxone | Each vial contains: | |||
Injection IP | Ceftriaxone Sodium (Sterile) | IP | |||
Eq. to Ceftriaxone | 1000 | mg | |||
11 | Cefepime Injection IP | Each vial contains: | |||
Cefepime Hydrochloride | IP | ||||
Eq. to Cefepime | 1000 | mg | |||
(Sterile Mixture of Cefepime Hydrochloride | |||||
And L-Arginine) | |||||
Each vial contains: | |||||
12 | Doxycycline for | Doxycycline Hydrochloride | IP | ||
Injection USP | Eq. to Doxycycline | 100 | mg | ||
Excipients | q.s. | ||||
Each vial contains: | |||||
13 | Meropenem Injection IP 1 g | Meropenem | IP | ||
equivalent to anhydrous Meropenem | 1000 | mg | |||
Sodium (As Sodium Carbonate IP) | 90.2 | mg | |||
14 | Pantoprazole for | Each vial contains: | |||
Injection BP | Pantoprazole Sodium (Sterile) | IP | |||
(Lyophilized) Eq. to Pantoprazole | 40 | mg | |||
15 | Piperacillin and Tazobactam | Each vial contains: | |||
Injection IP | Piperacillin Sodium | IP | |||
Eq. to Piperacillin | 4000 | mg | |||
Tazobactam Sodium | IP | ||||
Eq. to Tazobactam | 500 | mg | |||
16 | Colistimethate Sodium for | Each vial contains: | |||
Injection IP | Colistimethate Sodium | IP | 2 | Million IU | |
17 | Amoxycillin and Potassium | Each vial contains: | |||
Clavulanate Injection IP | Amoxycillin Sodium (Sterile) | IP | |||
Eq. to Anhydrous Amoxycillin | 500 | mg | |||
Potassium Clavulanate (Sterile) | IP | ||||
Eq. to Clavulanic Acid | 100 | mg | |||
18 | Amoxycillin and Potassium | Each vial contains: | |||
Clavulanate Injection IP | Amoxycillin Sodium (Sterile) | IP | |||
Eq. to Anhydrous Amoxycillin | 1000 | mg | |||
Potassium Clavulanate (Sterile) | IP | ||||
Eq. to Clavulanic Acid | 200 | mg | |||
19 | Rabeprazole | Each vial contains: | |||
Sodium Injection IP | Rabeprazole Sodium | IP | 20 | mg | |
(as Lyophilized Powder) | |||||
20 | Cefuroxime Sodium | Each vial contains: | |||
Injection IP | Cefuroxime Sodium | IP | |||
Eq. to Cefuroxime | 250 | mg | |||
21 | Cefuroxime Sodium | Each vial contains: | |||
Injection IP | Cefuroxime Sodium | IP | |||
Eq. to Cefuroxime | 750 | mg | |||
22 | Cefuroxime | Each vial contains: | |||
Injection IP | Cefuroxime Sodium | IP | |||
Eq. to Cefuroxime | 1500 | mg | |||
23 | Cefepime and Tazobactam | Each vial contains: | |||
Injection | Cefepime Hydrochloride | IP | |||
Eq. to Cefepime | 1000 | mg | |||
Tazobactam Sodium | IP | ||||
Eq. to Tazobactam | 125 | mg | |||
24 | Imipenem and Cilastatin | Each vial contains: | |||
Injection IP | Imipenem | IP | |||
Eq. to anhydrous Imipenem | 250 | mg | |||
Cilastatin Sodium | IP | ||||
Eq. to Cilastatin | 250 | mg | |||
25 | Imipenem and Cilastatin | Each vial contains: | |||
Injection IP | Imipenem | IP | |||
Eq. to anhydrous Imipenem | 500 | mg | |||
Cilastatin Sodium | IP | ||||
Eq. to Cilastatin | 500 | mg | |||
26 | Ceftazidime | Each vial contains: | |||
Injection IP | Ceftazidime (Sterile) | IP | |||
Eq. to anhydrous Ceftazidime | 250 | mg | |||
27 | Cefoperazone | Each vial contains: | |||
Injection IP | Cefoperazone Sodium (Sterile) | IP | |||
Eq. to Cefoperazone | 1 | gm | |||
28 | Meropenem and Sulbactam | Each vial contains: | |||
For Injection | Meropenem | IP | |||
Eq. to anhydrous Meropenem | 1000 | mg | |||
Sulbactam Sodium (Sterile) | IP | ||||
Eq. to Sulbactam | 500 | mg | |||
29 | Omeprazole | Each vial contains: | |||
Injection | Omeprazole Sodium | ||||
Eq. to Omeprazole | 40 | mg | |||
30 | Vancomycin Injection USP | Each vial contains: | |||
Vancomycin Hydrochloride | IP | ||||
Eq. to Vancomycin | 500 | mg | |||
31 | Vancomycin Injection USP | Each vial contains: | |||
Vancomycin Hydrochloride | IP | ||||
Eq. to Vancomycin | 1000 | mg | |||
32 | Aztreonam | Each vial contains: | |||
Injection USP | Aztreonam | USP | |||
Eq. to anhydrous Aztreonam | 500 | mg | |||
33 | Aztreonam | Each vial contains: | |||
Injection USP | Aztreonam | USP | |||
Eq. to anhydrous Aztreonam | 1 | gm | |||
34 | Aztreonam | Each vial contains: | |||
Injection USP | Aztreonam | USP | |||
Eq. to anhydrous Aztreonam | 2 | gm | |||
35 | Esomeprazole Sodium for | Each vial contains: | |||
Injection | Esomeprazole Sodium | ||||
Eq. to Esomeprazole | 40 | mg | |||
36 | Cefepime Injection IP | Each vial contains: | |||
Cefepime hydrochloride | IP | ||||
eq. to cefepime | 2000 | mg | |||
(sterile mixture of cefepime hydrochloride and L-arginine | |||||
37 | Cefepime and Tazobactam | Each vial contains: | |||
for Injection | Cefepime hydrochloride | IP | |||
eq. to cefepime | 250 | mg | |||
Tazobactam Sodium | IP | ||||
Eq. to Tazobactam | 31.25 | mg | |||
38 | Cefepime and Tazobactam | Each vial contains: | |||
for Injection | Cefepime hydrochloride | IP | |||
eq. to cefepime | 500 | mg | |||
Tazobactam Sodium | IP | ||||
Eq. to Tazobactam | 62.5 | mg | |||
39 | Cefoperazone and | Each vial contains: | |||
Sulbactam for Injection | Cefoperazone Sodium (Sterile) | IP | |||
Eq. to Cefoperazone | 1000 | mg | |||
Sulbactam Sodium (Sterile) | IP | ||||
Eq. to Sulbactam | 1000 | mg | |||
40 | Cefotaxime sodium | Each vial contains: | |||
Injection IP | |||||
Cefotaxime sodium | IP | ||||
Eq. to Cefotaxime | 1 | gm | |||
41 | Ceftazidime Injection IP | Each vial contains: | |||
Ceftazidime | IP | 250 | mg | ||
(As Ceftazidime Pentahydrate) | |||||
A blend of sterile ceftazidime pentahydrate & sterile sodium carbonate | |||||
42 | Ceftazidime Injection IP | Each vial contains: | |||
Ceftazidime | IP | 500 | mg | ||
(As Ceftazidime Pentahydrate) | |||||
A blend of sterile ceftazidime pentahydrate & sterile sodium carbonate | |||||
43 | Ceftazidime injection IP | Each vial contains: | |||
Ceftazidime | IP | 1 | gm | ||
(As Ceftazidime Pentahydrate) | |||||
A blend of sterile ceftazidime pentahydrate & sterile sodium carbonate | |||||
44 | Ceftazidime and Tazobactam | Each vial contains: | |||
injection | Ceftazidime | IP | 1000 | mg | |
(As Ceftazidime Pentahydrate) | |||||
A blend of sterile ceftazidime pentahydrate & sterile sodium carbonate | |||||
Tazobactam Sodium | IP | ||||
Eq. to Tazobactam | 125 | mg | |||
45 | Ceftriaxone Injection IP | Each vial contains: | |||
Ceftriaxone Sodium | IP | ||||
Eq. to Ceftriaxone | 2 | gm | |||
46 | Ceftriaxone and Sulbactam | Each vial contains: | |||
For Injection IP | Ceftriaxone Sodium | IP | |||
Eq. to Ceftriaxone | 2000 | mg | |||
Sulbactam Sodium | IP | ||||
Eq. to Sulbactam | 1000 | mg | |||
47 | Ceftriaxone and Tazobactam | Each vial contains: | |||
For Injection | Ceftriaxone Sodium | IP | |||
Eq. to Ceftriaxone | 250 | mg | |||
Tazobactam Sodium | IP | ||||
Eq. to Tazobactam | 31.25 | mg | |||
48 | Cefuroxime and Sulbactam | Each vial contains: | |||
For Injection | Cefuroxime Sodium | IP | |||
Eq. to Cefuroxime | 750 | mg | |||
Sulbactam Sodium | IP | ||||
Eq. to Sulbactam | 375 | mg | |||
49 | Cefuroxime and Sulbactam | Each vial contains: | |||
For Injection | Cefuroxime Sodium | IP | |||
Eq. to Cefuroxime | 1500 | mg | |||
Sulbactam Sodium | IP | ||||
Eq. to Sulbactam | 750 | mg | |||
50 | Imipenem and Cilastatin | Each vial contains: | |||
Injection IP | Imipenem | IP | |||
Eq. to anhydrous Imipenem | 1000 | mg | |||
Cilastatin Sodium | IP | ||||
Eq. to Cilastatin | 1000 | mg | |||
51 | Meropenem Injection IP | Each vial contains: | |||
Meropenem | IP | ||||
equivalent to anhydrous Meropenem | 250 | mg | |||
Sodium (As Sodium Carbonate IP) | 22.55 | mg | |||
52 | Meropenem Injection IP | Each vial contains: | |||
Meropenem | IP | ||||
equivalent to anhydrous Meropenem | 500 | mg | |||
Sodium (As Sodium Carbonate IP) | 45.1 | mg | |||
53 | Piperacillin and Tazobactam | Each vial contains: | |||
Injection IP | Piperacillin Sodium | IP | |||
Eq. to Piperacillin | 2000 | mg | |||
Tazobactam Sodium | IP | ||||
Eq. to Tazobactam | 250 | mg | |||
54 | Aciclovir | Each vial contains: | |||
Intravenous Infusion IP | Aciclovir Sodium | IP | |||
Eq. to Aciclovir | 500 | mg | |||
55 | Colistimethate Sodium for | Each vial contains: | |||
Injection IP | Colistimethate Sodium | IP | 1 | Million | |
IU | |||||
56 | Colistimethate Sodium for | Each vial contains: | |||
Injection IP | Colistimethate Sodium | IP | 0.5 | Million | |
IU | |||||
57 | Abatacept Powder For Injection | Each vial contains: | |||
Abatacept | 250 | mg | |||
Caspofungin | Each vial contains: | ||||
58 | Acetate For | ||||
Injection | Caspofungin Acetate | ||||
equivalent to Caspofungin | 50 | mg | |||
59 | Caspofungin | Each vial contains: | |||
Acetate For | |||||
Injection | Caspofungin Acetate | ||||
equivalent to Caspofungin | 70 | mg | |||
60 | Ertapenem For Injection | Each vial contains: | |||
Ertapenem Sodium | |||||
Eq. to Ertapenem | 1 | gm | |||
61 | Ceftazidime and Sulbactam | Each vial contains: | |||
Injection | Ceftazidime | IP | 500 | mg | |
(As Ceftazidime Pentahydrate) | |||||
A blend of sterile ceftazidime pentahydrate & sterile sodium carbonate | |||||
Sulbactam Sodium | IP | ||||
Eq. to Sulbactam | 250 | mg | |||
62 | Ceftazidime and Sulbactam | Each vial contains: | |||
Injection | Ceftazidime | IP | 1000 | mg | |
(As Ceftazidime Pentahydrate) | |||||
A blend of sterile ceftazidime pentahydrate & sterile sodium carbonate | |||||
Sulbactam Sodium | IP | ||||
Eq. to Sulbactam | 500 | mg | |||
63 | Ceftazidime and Sulbactam | Each vial contains: | |||
Injection | Ceftazidime | IP | 2 | gm | |
(As Ceftazidime Pentahydrate) | |||||
A blend of sterile ceftazidime pentahydrate & sterile sodium carbonate | |||||
Sulbactam Sodium | IP | ||||
Eq. to Sulbactam | 1 | gm | |||
64 | Cefepime and Amikacin | Each vial contains: | |||
for Injection | Cefepime hydrochloride | IP | |||
equivalent to Cefepime | 500 | mg | |||
Amikacin Sulphate | IP | ||||
equivalent to Amikacin | 125 | mg | |||
65 | Cefepime and Amikacin | Each vial contains: | |||
for Injection | Cefepime hydrochloride | IP | |||
equivalent to Cefepime | 1000 | mg | |||
Amikacin Sulphate | IP | ||||
equivalent to Amikacin | 250 | mg | |||
66 | Ceftazidime and Tobramycin For | Each vial contains: | |||
Injection | Ceftazidime | IP | |||
(As Ceftazidime Pentahydrate) | 500 | mg | |||
A blend of sterile ceftazidime pentahydrate & sterile sodium carbonate | |||||
Tobramycin Sulphate | USP | ||||
Eq. to Tobramycin | 60 | mg | |||
67 | Ceftazidime and Tobramycin For | Each vial contains: | |||
Injection | Ceftazidime | IP | |||
(As Ceftazidime Pentahydrate) | 1000 | mg | |||
A blend of sterile ceftazidime pentahydrate & sterile sodium carbonate | |||||
Tobramycin Sulphate | USP | ||||
Eq. to Tobramycin | 120 | mg | |||
68 | Azithromycin for | Each vial contains: | |||
Injection USP | Azithromycin (Anhydrous) | 500 | mg | ||
(as azithromycin Dihydrate IP ) | |||||
69 | Cefpirome and Sulbactam For Injection | Each vial contains: | |||
Cefpirome Sulphate | IP | ||||
equivalent to Cefpirome | 500 | mg | |||
Sulbactam Sodium | IP | ||||
Eq. to Sulbactam | 250 | mg | |||
70 | Cefpirome and Sulbactam | Each vial contains: | |||
For Injection | Cefpirome Sulphate | IP | |||
equivalent to Cefpirome | 1000 | mg | |||
Sulbactam Sodium | IP | ||||
Eq. to Sulbactam | 500 | mg | |||
71 | Cefpirome and Sulbactam | Each vial contains: | |||
For Injection | Cefpirome Sulphate | IP | |||
equivalent to Cefpirome | 2000 | mg | |||
Sulbactam Sodium | IP | ||||
Eq. to Sulbactam | 1000 | mg | |||
72 | Ticarcillin and Clavulanic Acid | Each vial contains: | |||
Injection IP | Ticarcillin Disodium | IP | |||
equivalent to Ticarcillin | 3 | g | |||
Clavulanate potassium | IP | ||||
Eq. to Clavulanic Acid | 100 | mg | |||
73 | Ceftriaxone | Each vial contains: | |||
Injection IP | |||||
Ceftriaxone Sodium | IP | ||||
Eq. to Ceftriaxone | 3 | g | |||
74 | Ceftriaxone and Sulbactam Injection | Eq. to Ceftriaxone | |||
( For Vet. Use ) | Ceftriaxone Sodium | IP | |||
Eq. to Ceftriaxone | 3000 | mg | |||
Sulbactam Sodium | IP | ||||
Eq. to Sulbactam | 1500 | mg | |||
75 | Cefoperazone and Sulbactam for | Each vial contains: | |||
Injection | |||||
( for Vet. Use ) | Cefoperazone Sodium (Sterile) | IP | |||
Eq. to Cefoperazone | 3000 | mg | |||
Sulbactam Sodium (Sterile) | IP | ||||
Eq. to Sulbactam | 1500 | mg | |||
76 | Tigecycline Injection IP | Each vial contains: | |||
Tigecycline | IP | 50 | mg | ||
77 | Voriconazole for | Each vial contains: | |||
Injection | Voriconazole | 200 | mg | ||
78 | Lansoprazole for | Each vial contains: | |||
Injection | |||||
Lansoprazole | IP | 30 | mg | ||
79 | Ceftriaxone | Each vial contains: | |||
Injection IP | |||||
( For Vet. Use ) | Ceftriaxone Sodium | IP | |||
Eq. to Ceftriaxone | 4 | g | |||
80 | Cefotaxime sodium | Each vial contains: | |||
Injection IP | Cefotaxime sodium | IP | |||
Eq. to Cefotaxime | 2 | g | |||
81 | Amoxycillin and Potassium | Each vial contains: | |||
Clavulanate Injection IP | Amoxycillin Sodium | IP | |||
equivalent to Amoxycillin | 250 | mg | |||
Potassium Clavulanate | IP | ||||
equivalent to Clavulanic Acid | 50 | mg | |||
82 | Chloramphenicol Sodium Succinate | Each vial contains: | |||
Injection IP | Chloramphenicol sodium succinate | IP | |||
equivalent to Chloramphenicol | 1000 | mg | |||
83 | Ceftazidime and Tazobactam | Each vial contains: | |||
Injection | Ceftazidime | IP | |||
(As Ceftazidime Pentahydrate) | 500 | mg | |||
A blend of sterile ceftazidime pentahydrate & sterile sodium carbonate | |||||
Tazobactam Sodium | IP | ||||
Eq. to Tazobactam | 62.5 | mg | |||
84 | Ampicillin Sodium Injection | Each vial contains: | |||
IP | Ampicillin Sodium | IP | |||
equivalent to Ampicillin | 500 | mg | |||
85 | Ampicillin Sodium Injection | Each vial contains: | |||
IP | Ampicillin Sodium | IP | |||
equivalent to Ampicillin | 1 | g | |||
86 | Doripenem | Each vial contains: | |||
Injection | Doripenem Monohydrate | ||||
equivalent to Doripenem | 250 | mg | |||
87 | Doripenem | Each vial contains: | |||
Injection | Doripenem Monohydrate | ||||
equivalent to Doripenem | 500 | mg | |||
88 | Meropenem Injection IP | Each vial contains: | |||
Meropenem | IP | ||||
equivalent to anhydrous Meropenem | 125 | mg | |||
Sodium (As Sodium Carbonate IP) | 11.28 | mg | |||
89 | Ampicillin and Sulbactam | Each vial contains: | |||
for Injection USP | Ampicillin Sodium | IP | |||
equivalent to Ampicillin | 1 | g | |||
Sulbactam Sodium | IP | ||||
Eq. to Sulbactam | 500 | mg | |||
90 | Teicoplanin | Each vial contains: | |||
Injection IP | Teicoplanin | IP | 200 | mg | |
91 | Teicoplanin | Each vial contains: | |||
Injection IP | Teicoplanin | IP | 400 | mg | |
92 | Thiopentone Sodium | Each vial contains: | |||
Injection IP | Thiopentone Sodium (Sterile) | IP | 1 | gm | |
93 | Cefpirome Sulphate | Each vial contains: | |||
Injection IP | Cefpirome Sulphate | IP | |||
eq.to Cefpirome | 1000 | mg | |||
94 | Artesunate | Each vial contains: | |||
Injection | Artesunate | IP | 120 | mg | |
95 | Ceftriaxone & Tazobactam | Each vial contains: | |||
for Injection | Ceftriaxone Sodium (Sterile) | IP | |||
Eq.to anhydrous Ceftriaxone | 250 | mg | |||
Tazobactam Sodium | IP | ||||
Eq. to anhydrous Tazobactam | 31.25 | mg | |||
96 | Cefepime and sulbactam for | Each vial contains: | |||
Injection | Cefepime Hydrochloride | IP | |||
equivalent to Cefepime | 500 | mg | |||
Sulbactam Sodium | IP | ||||
equivalent to Sulbactam | 250 | mg | |||
97 | Cefepime and sulbactam for | Each vial contains: | |||
Injection | Cefepime Hydrochloride | IP | |||
equivalent to Cefepime | 1000 | mg | |||
Sulbactam Sodium | IP | ||||
equivalent to Sulbactam | 500 | mg | |||
98 | Cefepime and sulbactam for | Each vial contains: | |||
Injection | Cefepime Hydrochloride | IP | |||
equivalent to Cefepime | 2000 | mg | |||
Sulbactam Sodium | IP | ||||
equivalent to Sulbactam | 1000 | mg | |||
99 | Cefotaxime | Each vial contains: | |||
Injection IP | Cefotaxime sodium | IP | |||
equivalent to Cefotaxime | 250 | mg | |||
100 | Cefotaxime | Each vial contains: | |||
Injection IP | Cefotaxime sodium | IP | |||
equivalent to Cefotaxime | 500 | mg | |||
101 | Cefazolin | Each vial contains: | |||
Injection IP | Cefazolin sodium | IP | |||
equivalent to Cefazolin | 500 | mg | |||
102 | Cefazolin | Each vial contains: | |||
Injection IP | Cefazolin sodium | IP | |||
equivalent to Cefazolin | 1000 | mg | |||
103 | Ceftriaxone and Tazobactam for | Each vial contains: | |||
Injection | Ceftriaxone Sodium (Sterile) | IP | |||
( For Vet. Use ) | Eq. to anhydrous Ceftriaxone | 2000 | mg | ||
Tazobactam Sodium (sterile) | IP | ||||
Eq. to anhydrous Tazobactam | 250 | mg | |||
104 | Ampicillin and Sulbactam for | Each vial contains: | |||
Injection USP | Ampicillin Sodium (Sterile) | IP | |||
( For Vet. Use ) | Eq. to anhydrous Ampicillin | 2000 | mg | ||
Sulbactam Sodium (Sterile) | IP | ||||
Eq. to anhydrous Sulbactam | 1000 | mg | |||
105 | Ampicillin and cloxacillin | Each vial contains: | |||
For Injection | Ampicillin Sodium (Sterile) | IP | |||
( For Vet. Use ) | Eq. to anhydrous Ampicillin | 1500 | mg | ||
Cloxacillin Sodium (Sterile) | IP | ||||
Eq. to anhydrous Cloxacillin | 1500 | mg | |||
106 | Ampicillin and cloxacillin | Each vial contains: | |||
For Injection | Ampicillin Sodium (Sterile) | IP | |||
( For Vet. Use ) | Eq. to anhydrous Ampicillin | 2000 | mg | ||
Cloxacillin Sodium (Sterile) | IP | ||||
Eq. to anhydrous Cloxacillin | 2000 | mg | |||
107 | Ceftriaxone and Sulbactam | Each vial contains: | |||
For Injection | Ceftriaxone Sodium (Sterile) | IP | |||
( For Vet. Use ) | Eq. to anhydrous Ceftriaxone | 2000 | mg | ||
Sulbactam Sodium (Sterile) | USP | ||||
Eq. to anhydrous Sulbactam | 1000 | mg | |||
108 | Cefotaxime & Sulbactam | Each vial contains: | |||
for Injection | Cefotaxime Sodium (Sterile) | IP | |||
Equivalent to Cefotaxime | 500 | mg | |||
Sulbactam Sodium | IP | ||||
Equivalent to Sulbactam | 250 | mg | |||
109 | Cefotaxime & Sulbactam | Each vial contains: | |||
for Injection | Cefotaxime Sodium (Sterile) | IP | |||
Equivalent to Cefotaxime | 1000 | mg | |||
Sulbactam Sodium | IP | ||||
Equivalent to Sulbactam | 500 | mg | |||
110 | Ceftriaxone and Sulbactam | Each vial contains: | |||
For Injection IP | Ceftriaxone Sodium | IP | |||
Equivalent to Ceftriaxone | 125 | mg | |||
Sulbactam Sodium | IP | ||||
Equivalent to Sulbactam | 62.5 | mg | |||
111 | Amoxycillin with Sulbactam | Each vial contains: | |||
For Injection | Amoxycillin Sodium | IP | |||
Equivalent to anhydrous Amoxycillin | 1000 | mg | |||
Sulbactam Sodium | IP | ||||
Equivalent to Sulbactam | 500 | mg | |||
112 | Amoxycillin with Sulbactam | Each vial contains: | |||
For Injection | Amoxycillin Sodium | IP | |||
Equivalent to anhydrous Amoxycillin | 500 | mg | |||
Sulbactam Sodium | IP | ||||
Equivalent to Sulbactam | 250 | mg | |||
113 | Cefepime Injection IP | Each vial contains: | |||
Cefepime Hydrochloride | IP | ||||
Eq. to Cefepime | 250 | mg | |||
(Sterile Mixture of Cefepime Hydrochloride | |||||
And L-Arginine) | |||||
114 | Cefepime Injection IP | Each vial contains: | |||
Cefepime Hydrochloride | IP | ||||
Eq. to Cefepime | 500 | mg | |||
(Sterile Mixture of Cefepime Hydrochloride | |||||
And L-Arginine) | |||||
115 | Ceftriaxone | Each vial contains: | |||
Injection IP | Ceftriaxone Sodium (Sterile) | IP | |||
Eq. to Ceftriaxone | 125 | mg | |||
116 | Cefuroxime Sodium | Each vial contains: | |||
Injection IP | Cefuroxime Sodium | IP | |||
Eq. to Cefuroxime | 500 | mg | |||
117 | Vancomycin Hydrochloride For Intravenous Infusion | Each vial contains: | |||
Vancomycin Hydrochloride | IP | ||||
Eq. to Vancomycin | 1000 | mg | |||
118 | Cefoperazone and | Each vial contains: | |||
Sulbactam For Injection | Cefoperazone Sodium (Sterile) | IP | |||
Eq. to Cefoperazone | 2000 | mg | |||
Sulbactam Sodium (Sterile) | IP | ||||
Eq. to Sulbactam | 1000 | mg | |||
119 | Cefuroxime and | Each vial contains: | |||
Sulbactam For Injection | Cefuroxime Sodium (Sterile) | IP | |||
Eq. to Cefuroxime | 1000 | mg | |||
Sulbactam Sodium (Sterile) | IP | ||||
Eq. to Sulbactam | 500 | mg | |||
120 | Methylprednisolone Sodium | Each vial contains: | |||
Succinate For Injection USP | Methylprednisolone Sodium Succinate | USP | |||
Eq. to Methylprednisolone | 125 | mg | |||
121 | Hydrocortisone Sodium | Each vial contains: | |||
Succinate Injection IP | Hydrocortisone Sodium Succinate | USP | |||
Equivalent to Hydrocortisone | 100 | mg | |||
122 | Cefoperazone Injection IP | Each vial contains: | |||
Cefoperazone Sodium | IP | ||||
Equivalent to Cefoperazone | 2000 | mg | |||
123 | Ceftriaxone and Tazobactam for | Each vial contains: | |||
Injection | Ceftriaxone Sodium | IP | |||
( For Vet. Use ) | Eq. to anhydrous Ceftriaxone | 3000 | mg | ||
Tazobactam Sodium | IP | ||||
Eq. to anhydrous Tazobactam | 375 | mg | |||
124 | Ceftriaxone and Tazobactam for | Each vial contains: | |||
Injection | Ceftriaxone Sodium | IP | |||
( For Vet. Use ) | Eq. to anhydrous Ceftriaxone | 4000 | mg | ||
Tazobactam Sodium | IP | ||||
Eq. to anhydrous Tazobactam | 500 | mg | |||
125 | Cefoperazone and Tazobactam for | Each vial contains: | |||
Injection | Cefoperazone Sodium | IP | |||
Equivalent to Cefoperazone | 1000 | mg | |||
Tazobactam Sodium | IP | ||||
Equivalent to anhydrous Tazobactam | 125 | mg | |||
126 | Cefoperazone and Tazobactam for | Each vial contains: | |||
Injection | Cefoperazone Sodium | IP | |||
Equivalent to Cefoperazone | 500 | mg | |||
Tazobactam Sodium | IP | ||||
Equivalent to anhydrous Tazobactam | 62.5 | mg | |||
127 | Amoxycillin and Cloxacillin for | Each vial contains: | |||
Injection | Amoxycillin Sodium | IP | |||
( For Vet. Use ) | Equivalent to anhydrous Amoxycillin | 1.5 | gm | ||
Cloxacillin Sodium | IP | ||||
Equivalent to anhydrous Cloxacillin | 1.5 | gm | |||
128 | Piperacillin and Tazobactam | Each vial contains: | |||
Injection IP | Piperacillin Sodium | IP | |||
Eq. to Piperacillin | 1000 | mg | |||
Tazobactam Sodium | IP | ||||
Eq. to Tazobactam | 125 | mg | |||
129 | Fosfomycin Sodium For Injection | Each vial contains: | |||
4 gm | Fosfomycin Sodium | IP | |||
Equivalent to Fosfomycin | 4 | gm | |||
130 | Amoxycillin and Cloxacillin for | Each vial contains: | |||
Injection | Amoxycillin Sodium | IP | |||
( For Vet. Use ) | Equivalent to anhydrous Amoxycillin | 1.75 | gm | ||
Cloxacillin Sodium | IP | ||||
Equivalent to anhydrous Cloxacillin | 1.75 | gm | |||
131 | Amoxycillin and Cloxacillin for | Each vial contains: | |||
Injection | Amoxycillin Sodium | IP | |||
( For Vet. Use ) | Equivalent to anhydrous Amoxycillin | 2 | gm | ||
Cloxacillin Sodium | IP | ||||
Equivalent to anhydrous Cloxacillin | 2 | gm | |||
132 | Ceftiofur Sodium Sterile Powder | Each vial contains: | |||
For Injection 1 g | Ceftiofur Sodium | IP | |||
( For Vet. Use ) | Equivalent to Ceftiofur | 1 | gm | ||
133 | Glutathione For Injection | Each vial contains: | |||
Glutathione | BP | 600 | mg | ||
134 | Glutathione For Injection | Each vial contains: | |||
Glutathione | BP | 1200 | mg | ||
135 | Hydrocortisone Sodium | Each vial contains: | |||
Succinate Injection IP | Hydrocortisone Sodium Succinate | USP | 200 | mg | |
Eq. to Hydrocortisone | |||||
136 | Methylprednisolone Sodium | Each vial contains: | |||
Succinate Injection USP | Methylprednisolone Sodium Succinate (Sterile) | USP | |||
Eq. to Anhydrous Methylprednisolone | 500 | mg | |||
137 | Methylprednisolone Sodium | Each vial contains: | |||
Succinate Injection USP | Methylprednisolone Sodium Succinate (Sterile) | USP | |||
Eq. to Anhydrous Methylprednisolone | 1000 | mg | |||
138 | Ceftriaxone & Tazobactam | Each vial contains: | |||
for Injection | Ceftriaxone Sodium | IP | |||
equivalent to anhydrous Ceftriaxone | 500 | mg | |||
Tazobactam Sodium | IP | ||||
equivalent to anhydrous Tazobactam | 62.5 | mg | |||
139 | Ceftriaxone & Tazobactam | Each vial contains: | |||
for Injection | Ceftriaxone Sodium | IP | |||
equivalent to anhydrous Ceftriaxone | 125 | mg | |||
Tazobactam Sodium | IP | ||||
equivalent to anhydrous Tazobactam | 15.625 | mg | |||
140 | Ceftriaxone & Tazobactam | Each vial contains: | |||
for Injection | Ceftriaxone Sodium | IP | |||
equivalent to anhydrous Ceftriaxone | 2 | gm | |||
Tazobactam Sodium | IP | ||||
equivalent to anhydrous Tazobactam | 250 | mg | |||
141 | Ceftazidime and Tazobactam | Each vial contains: | |||
injection | Ceftazidime | IP | 250 | mg | |
(As Ceftazidime Pentahydrate) | |||||
A blend of sterile ceftazidime pentahydrate & sterile sodium carbonate | |||||
Tazobactam Sodium | IP | ||||
equivalent to anhydrous Tazobactam | 31.25 | mg | |||
142 | Sulbactam Injection IP | Each vial contains: | |||
Sulbactam Sodium | IP | ||||
equivalent to Sulbactam | 1000 | mg | |||
143 | Each vial contains: | ||||
Methylprednisolone Sodium Succinate For Injection USP | Methylprednisolone Sodium Succinate (Sterile) | ||||
equivalent to Anhydrous Methylprednisolone | USP | 40 | mg | ||
144 | Each vial contains: | ||||
Cerebroprotein Hydrolysate For Injection 60 mg | Cerebroprotein Hydrolysate 2100 mg approx) | ||||
equivalent to Nitrogen | 60 | mg | |||
Excipients | q.s. | ||||
145 | Meropenem and Tazobactam | Each vial contains: | |||
For Injection | Sterile Meropenem Trihydrate | IP | 1000 | mg | |
Eq. to Anhydrous Meropenem | |||||
Sodium Carbonate | IP | ||||
Eq. to Sodium | 86 | mg | |||
TazobactamSodium (Sterile) | IP | ||||
Eq. to Anhydrous Tazobactam | 125 | mg | |||
146 | Meropenem and Sulbactam | Each vial contains: | |||
For Injection | Meropenem (Sterile) | IP | 1000 | mg | |
Eq. to Anhydrous Meropenem | |||||
(A Sterile Mixture of Meropenem IP & Sodium Carbonate IP | |||||
Sulbactam Sodium (Sterile) | IP | ||||
Eq. to Sulbactam | 500 | mg | |||
Disodium EDTA | IP | 37.5 | mg | ||
147 | Ceftriaxone & Tazobactam | Each vial contains: | |||
For Injection | Ceftriaxone Sodium (Sterile) | IP | |||
Equivalent to Anhydrous Ceftriaxone | 1000 | mg | |||
Tazobactam Sodium (Sterile) | IP | ||||
Equivalent to Anhydrous Tazobactam | 125 | mg | |||
Disodium EDTA | IP | 37.5 | mg | ||
148 | Piperacillin & Tazobactam | Each vial contains: | |||
For Injection IP with Disodium EDTA | Sterile Piperacillin Sodium | IP | |||
Equivalent to Anhydrous Piperacillin | 4 | gm | |||
Sterile Tazobactam Sodium | IP | ||||
Equivalent to Anhydrous Tazobactam | 500 | mg | |||
Disodium EDTA | IP | 1 | mg |
Why is Broad Injectables the right choice for injection-making in India?
Our company has always been one of the top third party injection manufacturers in India. Those businesses or customers who come to our company always get the benefits of our cheaper labor and operating expenses. They don’t need to invest huge amounts of money in the production department of their firms. Moreover, by getting our services, healthcare organizations focus on their core strengths, such as research, development, and marketing, rather than manufacturing logistics. Instead of focusing on manufacturing processes, they use their resources for better-directed innovation.
In addition, our whole team of third-party manufacturers has particular skills and knowledge in making certain healthcare items that always provide high-quality results. Along with this, we have access to cutting-edge manufacturing technology and procedures, which boost product quality and efficiency very well. Most importantly, our company is always engaged in continuous improvement practices and innovation. This allows our customers to always get new and better-quality products.
Consequently, we hope that you all now understand that outsourcing injection manufacturing services to experts is very beneficial for your pharma products business. There are various types of benefits and services you can get from third-party manufacturers. Hence, if you want to work with the top injection manufacturers in India, call Broad Injectables.